Hospitalist Doctors in Muskegon, MI Accepting Medicare

10 Hospitalist doctors found. Showing 1 - 10

Kyle Nathaniel Turcic, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000

Bartholomew David Sak, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883    Fax: 231-672-3973

Dr. Peyton Paul Faganel, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St Ste 201a, Muskegon, MI 49442 Phone: 231-672-7800

Jon Michael Carnahan, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883    Fax: 231-672-3973

Dr. Sripriya Ganesan, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1675 Leahy St Ste 304b, Muskegon, MI 49442 Phone: 231-728-1695

Matthew Anthony Wagner, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000

Dr. William Patrick Hughes, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883    Fax: 231-672-3973

Dr. Adam Vaughn, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883    Fax: 231-672-3973

Kyle Robert Ulrich, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883    Fax: 231-672-3973

Vitalie V Ureche, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-3883    Fax: 231-672-3973

News Archive

Overhaul may cost drugmakers more than expected

Bloomberg BusinessWeek: The health overhaul legislation will likely cost drugmakers $25 billion more than the $80 billion the industry anticipated when it agreed to back the Democratic-led effort, according to Wall Street analysts. "The extra costs will come from expanding drug rebates through Medicaid, the U.S. insurance program for the poor, [Leerink Swann & Co executive] John L. Sullivan said today at a Bloomberg conference in Chicago."

Study shows how T cell's machinery dials down autoimmunity

A St. Jude Children's Research Hospital study shows that T cells, the body's master immune regulators, do not use simple on/off switches to govern the cellular machinery that regulates their development and function. Rather, they possess sophisticated molecular controls that enable them to adjust their function with exquisite precision. Such subtle adjustment enables T cells to modulate their development and function, including avoiding autoimmunity

Prosecutor calls for death penalty for Bulgarian nurses in Libya

A Libyan prosecutor on Tuesday issued another call for the execution of five Bulgarian nurses and a Palestinian doctor on trial for allegedly infecting Libyan children with HIV, the New York Times reports (Smith, New York Times, 8/30).

Positive results from POZEN's PA32540 Phase 3 trials presented at AHA Scientific Sessions 2012

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results from two pivotal Phase 3 clinical trials of the investigational product, PA32540, at The American Heart Association (AHA) Scientific Sessions 2012, as Poster #12057: Treatment Continuation and Cardiovascular Safety of Antiplatelet Therapy with PA32540, A Tablet with Enteric-Coated Aspirin and Immediate-Release Omeprazole: Results of Two 6-Month, Phase 3 Studies.

Subset of TH17 cells linked to inflammation in Crohn's disease patients, find TSRI scientists

Two-thirds to three-quarters of the estimated 700,000 Americans living with Crohn's disease, an autoimmune condition that can disrupt the entire gastrointestinal tract, will require surgery at some point during their life. Patients and physicians often turn to this surgical intervention after a patient develops resistance to current treatments, such as steroids.

Read more Medical News

› Verified 5 days ago